CANCIDAS
These highlights do not include all the information needed to use CANCIDAS safely and effectively. See full prescribing information for CANCIDAS. CANCIDAS® (caspofungin acetate) for injection, for intravenous useInitial U.S. Approval: 2001
3bad23a6-09a6-4194-9182-093ed61bc71c
HUMAN PRESCRIPTION DRUG LABEL
Nov 20, 2023
Merck Sharp & Dohme LLC
DUNS: 118446553
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
CASPOFUNGIN ACETATE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (5)
CASPOFUNGIN ACETATE
Product Details
FDA regulatory identification and product classification information
